New COVID-19 Rapid Research Funding to support a network of clinical trials networks – EOI
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with your unit
Memorial Deadline: No RGCS review required for the Expression of Interest Stage
External Deadline: Monday 16th, November 2020
Description
The Government of Canada would like to provide information on an upcoming launch of a rapid research response to continue to mobilize science to fight COVID-19. We are providing preliminary information at this time to allow the research community to prepare and respond to an expedited process.
The funding will support the establishment and/or expansion of a network of existing Clinical Trials groups/networks to collaborate and coordinate research on interventions to prevent, detect, manage, and/or treat COVID-19. Specifically, this funding will:
- *Establish central coordination and collaboration activities with existing clinical trials groups/networks to increase the availability of high-quality and real-time evidence and build capacity to support Canada’s rapid response to the global pandemic and health emergencies in order to better prevent, detect, treat and/or manage COVID-19;
- *Establish a transparent, inclusive, multi-jurisdictional recruitment and membership process that describes benefits for and requirements and expectations of members;
- *Collaborate across member networks to establish resource and data sharing policies, increase efficiencies in research and related processes (including, but not limited to ethics review; contracts; common protocols; developing applications for trial funding; consistent and valid patient-oriented outcomes), reduce duplication, and maximize research impact for COVID-19;
- *Create data sharing agreements to ensure follow-up of patients through existing administrative data platforms within Canada;
- *Adopt a nimble and adaptive strategy for engaging stakeholders in research prioritization and oversight while shifting studies as needed, based on new knowledge and changing COVID-19 landscape;
- *Provide evidence to inform clinical and health system management and public health response, and/or decision-making and planning within and across jurisdictions in Canada and internationally; and,
- *Enhance local, national and/or international clinical trial collaborative efforts by aligning clinical trials networks with other COVID-19 research investments to prevent and/or mitigate the rapid spread of COVID-19 and related negative consequences.
Expected key dates
- Launch: November 10, 2020
- EOI deadline: November 16, 2020
- Application deadline: November 27, 2020
- Notice of decision: December 22, 2020
- Funding start date: December 1, 2020
Additional information can be found here.